EDP Sciences logo
Search
Menu
All issues Volume 40 / No 6 (November-December 2009) Vet. Res., 40 6 (2009) 62 References
Open Access
Issue
Vet. Res.
Volume 40, Number 6, November-December 2009
Number of page(s) 15
DOI https://doi.org/10.1051/vetres/2009047
Published online 13 August 2009
How to cite this article Vet. Res. (2009) 40:62
References of  Vet. Res. (2009) 40:62
  1. Alderson T., The mechanism of formaldehydeinduced mutagenesis The monohydroxymethlyation reaction of formaldehyde with adenylic acid as the necessary and sufficient condition for the mediation of the mutagenic activity of formaldehyde, Mutat. Res. (1964) 106:77–85 [PubMed].
  2. Berhane Y., Berry J.D., Ranadheera C., Marszal P., Nicolas B., Yuan X., et al., Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus, J. Virol. Methods (2006) 132:59–68 [CrossRef] [PubMed].
  3. Botner A., Nielsen J., Oleksiewicz M.B., Storgaard T., Heterologous challenge with porcine reproductive and respiratory syndrome (PRRS) vaccine virus: no evidence of reactivation of previous European-type PRRS virus infection, Vet. Microbiol. (1999) 68:187–195 [CrossRef] [PubMed].
  4. Broo K., Wei J., Marshall D., Brown F., Smith T.J., Johnson J.E., et al., Viral capsid mobility: a dynamic conduit for inactivation, Proc. Natl. Acad. Sci. USA (2001) 98:2274–2277 [CrossRef] [PubMed].
  5. Cancel-Tirado S.M., Evans R.B., Yoon K.J., Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection, Vet. Immunol. Immunopathol. (2004) 102:249–262 [CrossRef] [PubMed].
  6. Cavanagh D., Nidovirales: a new order comprising Coronaviridae and Arteriviridae, Arch. Virol. (1997) 142:629–633 [PubMed].
  7. Chertova E., Crise B.J., Morcock D.R., Bess J.W. Jr, Henderson L.E., Lifson J.D., Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins, Curr. Mol. Med. (2003) 3:265–272 [CrossRef] [PubMed].
  8. Cheung D.T., Nimni M.E., Mechanism of crosslinking of proteins by glutaraldehyde II. Reaction with monomeric and polymeric collagen, Connect. Tissue Res. (1982) 10:201–216 [CrossRef] [PubMed].
  9. Christianson W.T., Choi C.S., Collins J.E., Molitor T.W., Morrison R.B., Joo H.S., Pathogenesis of porcine reproductive and respiratory syndrome virus infection in mid-gestation sows and fetuses, Can. J. Vet. Res. (1993) 57:262–268 [PubMed].
  10. Christopher-Hennings J., Nelson E.A., Nelson J.K., Benfield D.A., Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars, Am. J. Vet. Res. (1997) 58:40–45 [PubMed].
  11. Conzelmann K.K., Visser N., Van Woensel P., Thiel H.J., Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group, Virology (1993) 193:329–339 [CrossRef] [PubMed].
  12. Cowley J.A., Dimmock C.M., Spann K.M., Walker P.J., Gill-associated virus of Penaeus monodon prawns: an invertebrate virus with ORF1a and ORF1b genes related to arteri- and coronaviruses, J. Gen. Virol. (2000) 81:1473–1484 [PubMed].
  13. Cranage M.P., McBride B.W., Rud E.W., The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine, Vaccine (1995) 13:895–900 [CrossRef] [PubMed].
  14. Darnell M.E., Subbarao K., Feinstone S.M., Taylor D.R., Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARSCoV, J. Virol. Methods (2004) 121:85–91 [CrossRef] [PubMed].
  15. Delputte P.L., Meerts P., Costers S., Nauwynck H.J., Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages, Vet. Immunol. Immunopathol. (2004) 102:179–188 [CrossRef] [PubMed].
  16. Delputte P.L., Costers S., Nauwynck H.J., Analysis of porcine reproductive and respiratory syndrome virus attachment and internalization: distinctive roles for heparan sulphate and sialoadhesin, J. Gen. Virol. (2005) 86:1441–1445 [CrossRef] [PubMed].
  17. Delputte P.L., Van Breedam W., Barbe F., Van Reeth K., Nauwynck H.J., IFN-alpha treatment enhances porcine Arterivirus infection of monocytes via upregulation of the porcine Arterivirus receptor sialoadhesin, J. Interferon Cytokine Res. (2007) 27:757–766 [CrossRef] [PubMed].
  18. Dewey C.E., Wilson S., Buck P., Leyenaar J.K., The reproductive performance of sows after PRRS vaccination depends on stage of gestation, Prev. Vet. Med. (1999) 40:233–241 [CrossRef] [PubMed].
  19. Di Trani L., Cordioli P., Falcone E., Lombardi G., Moreno A., Sala G., Tollis M., Standardization of an inactivated H17N1 avian influenza vaccine and efficacy against A/Chicken/Italy/13474/99 highpathogenicity virus infection, Avian Dis. (2003) 47:1042–1046 [CrossRef] [PubMed].
  20. Feron V.J., Til H.P., de Vrijer F., Woutersen R.A., Cassee F.R., van Bladeren P.J., Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment, Mutat. Res. (1991) 259:363–385 [CrossRef] [PubMed].
  21. Fournier-Caruana J., Poirier B., Haond G., Jallet C., Fuchs F., Tordo N., Perrin P., Inactivated rabies vaccine control and release: use of an ELISA method, Biologicals (2003) 31:9–16 [CrossRef] [PubMed].
  22. Fraenkel-Conrat H., Reaction of nucleic acid with formaldehyde, Biochim. Biophys. Acta (1954) 15:307–309 [CrossRef] [PubMed].
  23. Gates K.S., Nooner T., Dutta S., Biologically relevant chemical reactions of N7-alkylguanine residues in DNA, Chem. Res. Toxicol. (2004) 17:839–856 [CrossRef] [PubMed].
  24. Grieb T., Forng R.Y., Brown R., Owolabi T., Maddox E., McBain A., et al., Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations, Biologicals (2002) 30:207–216 [CrossRef] [PubMed].
  25. Grovit-Ferbas K., Hsu J.F., Ferbas J., Gudeman V., Chen I.S., Enhanced binding of antibodies to neutralization epitopes following thermal and chemical inactivation of human immunodeficiency virus type 1, J. Virol. (2000) 74:5802–5809 [CrossRef] [PubMed].
  26. Knipe D.M., Howley P.M., Fields virology, 5th ed., Lippincott Williams & Wilkins, 2006.
  27. Kuykendall J.R., Bogdanffy M.S., Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro, Mutat. Res. (1992) 283:131–136 [CrossRef] [PubMed].
  28. Labarque G., Van Gucht S., Van Reeth K., Nauwynck H., Pensaert M., Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines, Vet. Microbiol. (2003) 95:187–197 [CrossRef] [PubMed].
  29. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M., Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy, Vaccine (2004) 22:4183–4190 [CrossRef] [PubMed].
  30. Labarque G.G., Nauwynck H.J., Van Reeth K., Pensaert M.B., Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs, J. Gen. Virol. (2000) 81:1327–1334 [PubMed].
  31. Lelie P.N., Reesink H.W., Lucas C.J., Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine, J. Med. Virol. (1987) 23:297–301 [CrossRef] [PubMed].
  32. Ma T.H., Harris M.M., Review of the genotoxicity of formaldehyde, Mutat. Res. (1988) 196:37–59 [PubMed].
  33. Maheshwari G., Jannat R., McCormick L., Hsu D., Thermal inactivation of adenovirus type 5, J. Virol. Methods (2004) 118:141–146 [CrossRef] [PubMed].
  34. Meng X.J., Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development, Vet. Microbiol. (2000) 74:309–329 [CrossRef] [PubMed].
  35. Mengeling W.L., Lager K.M., Vorwald A.C., Temporal characterization of transplacental infection of porcine fetuses with porcine reproductive and respiratory syndrome virus, Am. J. Vet. Res. (1994) 55:1391–1398 [PubMed].
  36. Mengeling W.L., Lager K.M., Vorwald A.C., Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome, Am. J. Vet. Res. (1999) 60:796–801 [PubMed].
  37. Meulenberg J.J., Hulst M.M., de Meijer E.J., Moonen P.L., den Besten A., de Kluyver E.P., et al., Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV, Virology (1993) 192:6–72.
  38. Meulenberg J.J., Petersen-den Besten A., De Kluyver E.P., Moormann R.J., Schaaper W.M., Wensvoort G., Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus, Virology (1995) 206:155–163 [CrossRef] [PubMed].
  39. Meulenberg J.J., van Nieuwstadt A.P., van Essen-Zandbergen A., Langeveld J.P., Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus, J. Virol. (1997) 71:6061–6067 [PubMed].
  40. Miller R.L., Plagemann P.G., Effect of ultraviolet light on mengovirus: formation of uracil dimers, instability and degradation of capsid, and covalent linkage of protein to viral RNA, J. Virol. (1974) 13:729–739 [PubMed].
  41. Misinzo G., Delputte P.L., Meerts P., Drexler C., Nauwynck H.J., Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge, Adv. Exp. Med. Biol. (2006) 581:449–454 [PubMed].
  42. Mondal S.K., Neelima M., Seetha Rama Reddy K., Ananda Rao K., Srinivasan V.A., Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production, Biologicals (2005) 33:185–189 [PubMed].
  43. Morgeaux S., Milne C., Daas A., Feasibility study to develop a common in vitro D antigen assay for inactivated poliomyelitis vaccines, Pharmeuropa Bio (2005) 2005:19–26 [PubMed].
  44. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., et al., Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States, J. Am. Vet. Med. Assoc. (2005) 227:385–392 [CrossRef] [PubMed].
  45. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Botner A., Storgaard T., Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations, J. Gen. Virol. (2001) 82:1263–1272 [PubMed].
  46. Nielsen J., Botner A., Bille-Hansen V., Oleksiewicz M.B., Storgaard T., Experimental inoculation of late term pregnant sows with a field isolate of porcine reproductive and respiratory syndrome vaccine-derived virus, Vet. Microbiol. (2002) 84:1–13 [CrossRef] [PubMed].
  47. Nielsen T.L., Nielsen J., Have P., Baekbo P., Hoff-Jorgensen R., Botner A., Examination of virus shedding in semen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive and respiratory syndrome virus, Vet. Microbiol. (1997) 54:101–112 [CrossRef] [PubMed].
  48. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., Lopez O.J., Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain, J. Virol. (2002) 76:4241–4250 [CrossRef] [PubMed].
  49. Permana P.A., Snapka R.M., Aldehyde-induced protein-DNA crosslinks disrupt specific stages of SV40 DNA replication, Carcinogenesis (1994) 15:1031–1036 [CrossRef] [PubMed].
  50. Poon B., Safrit J.T., McClure H., Kitchen C., Hsu J.F., Gudeman V., et al., Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1, J. Virol. (2005) 79:4927–4935 [CrossRef] [PubMed].
  51. Prieto C., Suarez P., Bautista J.M., Sanchez R., Rillo S.M., Simarro I., et al., Semen changes in boars after experimental infection with porcine reproductive and respiratory syndrome (PRRS) virus, Theriogenology (1996) 45:383–395 [CrossRef] [PubMed].
  52. Rodriguez M.J., Sarraseca J., Fominaya J., Cortes E., Sanz A., Casal J.I., Identification of an immunodominant epitope in the C terminus of glycoprotein 5 of porcine reproductive and respiratory syndrome virus, J. Gen. Virol. (2001) 82:995–999 [PubMed].
  53. Rooijakkers E.J., Uittenbogaard J.P., Groen J., Osterhaus A.D., Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing, J. Virol. Methods (1996) 58:111–119 [CrossRef] [PubMed].
  54. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess J.W. Jr, Vasquez G.M., et al., Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins, J. Virol. (1998) 72:7992–8001 [PubMed].
  55. Rossow K.D., Bautista E.M., Goyal S.M., Molitor T.W., Murtaugh M.P., Morrison R.B., et al., Experimental porcine reproductive and respiratory syndrome virus infection in one-, four-, and 10-week-old pigs, J. Vet. Diagn. Invest. (1994) 6:3–12 [PubMed].
  56. Schlegel A., Immelmann A., Kempf C., Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride, Transfusion (2001) 41:382–389 [CrossRef].
  57. Sinha R.P., Hader D.P., UV-induced DNA damage and repair: a review, Photochem. Photobiol. Sci. (2002) 1:225–236 [CrossRef] [PubMed].
  58. Subasinghe H.A., Loh P.C., Reovirus cytotoxicity: some properties of the UV-irradiated reovirus and its capsid proteins, Arch. Gesamte Virusforsch. (1972) 39:172–189 [CrossRef] [PubMed].
  59. Terpstra C., Wensvoort G., Pol J.M., Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled, Vet. Q. (1991) 13:131–136 [PubMed].
  60. Van Gorp H., Van Breedam W., Delputte P.L., Nauwynck H.J., Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus, J. Gen. Virol. (2008) 89:2943–2953 [CrossRef] [PubMed].
  61. Vanderheijden N., Delputte P.L., Favoreel H.W., Vandekerckhove J., Van Damme J., van Woensel P.A., Nauwynck H.J., Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages, J. Virol. (2003) 77:8207–8215 [CrossRef] [PubMed].
  62. Weismiller D.G., Sturman L.S., Buchmeier M.J., Fleming J.O., Holmes K.V., Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions, J. Virol. (1990) 64:3051–3055 [PubMed].
  63. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., et al., Mystery swine disease in The Netherlands: the isolation of Lelystad virus, Vet. Q. (1991) 13:121–130 [PubMed].
  64. Wieczorek-Krohmer M., Weiland F., Conzelmann K., Kohl D., Visser N., van Woensel P., et al., Porcine reproductive and respiratory syndrome virus (PRRSV): monoclonal antibodies detect common epitopes on two viral proteins of European and U.S. isolates, Vet. Microbiol. (1996) 51:257–266 [CrossRef] [PubMed].
  65. Williams M.C., Gorelick R.J., Musier-Forsyth K., Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function, Proc. Natl. Acad. Sci. USA (2002) 99:8614–8619 [CrossRef] [PubMed].
  66. Wissink E.H., van Wijk H.A., Kroese M.V., Weiland E., Meulenberg J.J., Rottier P.J., van Rijn P.A., The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain, J. Gen. Virol. (2003) 84:1535–1543 [CrossRef] [PubMed].
  67. Wootton S.K., Yoo D., Homo-oligomerization of the porcine reproductive and respiratory syndrome virus nucleocapsid protein and the role of disulfide linkages, J. Virol. (2003) 77:4546–4557 [CrossRef] [PubMed].
  68. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F., Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge, Vet. Microbiol. (2007) 123:69–85 [CrossRef] [PubMed].